October 21, 2025

Get In Touch

Rajasthan Chemists Warn of Indefinite Strike Over Rs 880 Crore Unpaid Govt Dues

Jaipur:A major crisis is brewing in Rajasthan's healthcare supply chain, with chemists and pharmacists across the state warning of an indefinite strike over unpaid government dues of nearly Rs 880 crore. The mounting backlog has left thousands of medical shops and suppliers struggling to stay afloat, sparking concerns of medicine shortages if the issue remains unresolved. Chemists allege that payments for medicines supplied to government hospitals, primary health centres, and other facilities have been delayed for months. Many small-scale shop owners say they are under severe financial strain, with distributors unwilling to provide fresh stock while earlier bills remain pending. The situation, they warn, could soon bring routine supplies of essential drugs to a grinding halt. Representatives of chemist associations have demanded immediate intervention from the state government and a fixed timeline for clearance of outstanding bills. They argue that while promises have been made on multiple occasions, concrete action is missing, leaving over 10,000 pharmacies affected. For many, cash flow has dried up to the extent that staff salaries and basic operations have become difficult to sustain. Also Read:Chemist Body Seeks Transition Period, GST Input Adjustment After Tax Cut, Writes to CM The associations are now preparing to escalate their agitation and have indicated that if dues are not cleared promptly, supply to government institutions will be stopped. This would directly hit patient care in public health facilities, especially those in rural areas heavily dependent on state-run medical services. According to PTI, the chemists’ bodies have already sent repeated representations to the health department, but with no satisfactory response so far. The looming strike, if carried out, could have a ripple effect on healthcare delivery across Rajasthan. Also Read:Puducherry launches raids against private chemists flouting norms on anti-TB drugs sale

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!